Delivery Order SPE2DE24D0013-SPE2D626F24CC
- Not listed
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a $34,000 firm fixed-price delivery order (Contract 4570371726, XPRS4PLEX-10) by the Defense Logistics Agency Medical Supply Chain on December 29, 2025, with an ultimate completion date of January 6, 2026. This delivery order, which carries no set-aside designation, is issued under Cepheid's existing Indefinite Delivery Contract with the Department of Veterans Affairs Veterans Integrated Service Network (VISN) 17, valued at...
- The Defense Logistics Agency Medical Supply Chain has awarded a delivery order valued at $14,552 to Cepheid Inc. under an Indefinite Delivery Contract with the Department of Veterans Affairs VISN 17. This firm fixed-price delivery order, issued on January 21, 2026, with an ultimate completion date of January 28, 2026, pertains to XPRS4PLEX-10 cartridges—molecular diagnostic reagents designed for Cepheid's GeneXpert diagnostic platform. The order represents a child contract without set-aside...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a $7,480 firm fixed-price delivery order by the Defense Logistics Agency Medical Supply Chain on January 7, 2026, with an ultimate completion date of January 14, 2026. This delivery order, valued at the ceiling amount, is issued under Cepheid's larger Indefinite Delivery Contract with the Department of Veterans Affairs Veterans Integrated Service Network 17, which is valued at $6.7...
- The Defense Logistics Agency Medical Supply Chain awarded a $5,440 firm fixed-price delivery order to Cepheid Inc. on January 13, 2026, with an ultimate completion date of January 21, 2026. This delivery order, identified as XPRS4PLEX-10, is a child contract issued under Cepheid's existing Indefinite Delivery Contract with the Department of Veterans Affairs VISN 6, valued at $32.8 million and extending through September 30, 2030. The contract involves the supply of molecular diagnostic testing...
- The Defense Logistics Agency Medical Supply Chain awarded a $2,040 firm fixed-price delivery order to Cepheid Inc. on January 20, 2026, with an ultimate completion date of January 27, 2026. This delivery order, designated XPRS4PLEX-10, represents a child contract under Cepheid's larger Indefinite Delivery Contract framework with the Department of Veterans Affairs Veterans Integrated Service Network (VISN) 17, valued at $6.74 million through December 28, 2029. The delivery order procures...
- The Defense Logistics Agency's Medical Supply Chain division awarded a $6,800 firm fixed-price delivery order to Cepheid Inc. on January 14, 2026, under contract number 4570533423 (XPRS4PLEX-10). This delivery order is a child contract issued under one of Cepheid's existing Indefinite Delivery Contracts with the Department of Veterans Affairs. The order calls for the delivery of XPRS4PLEX-10 cartridges and related molecular diagnostic testing reagents and assays designed for use with Cepheid's...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a $2,040 firm fixed-price delivery order (4570331464 | XPRS4PLEX-10) by the Defense Logistics Agency Medical Supply Chain on December 19, 2025, with an ultimate completion date of December 29, 2025. This delivery order, which carries no set-aside designation, is issued under Cepheid's larger Indefinite Delivery Contract with the Department of Veterans Affairs VISN 17, valued at $6.7...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a delivery order valued at $73,440 by the Defense Logistics Agency's Medical Supply Chain on January 16, 2026. This firm fixed-price delivery order, set to be completed by January 26, 2026, represents a child contract under a larger Indefinite Delivery Vehicle (IDV) with the Department of Veterans Affairs. The delivery order is expected to be performed at Cepheid's Sunnyvale location...
- The Defense Logistics Agency Medical Supply Chain awarded Cepheid Inc. a $4,416.00 delivery order on January 12, 2026, under contract number XPRSTREPA-10, with performance completion targeted for January 20, 2026. This firm fixed-price delivery order, which is not set-aside designated, represents a child contract under Cepheid's larger indefinite delivery vehicle with the Department of Veterans Affairs and reflects continued procurement of molecular diagnostic solutions. The order will be...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a $4,620 firm fixed-price delivery order by the Defense Logistics Agency Medical Supply Chain on January 13, 2026, with an ultimate completion date of January 21, 2026. This delivery order, designated XPRS-COV2-10, represents a child contract issued under Cepheid's broader Indefinite Delivery Contract with the Department of Veterans Affairs Veterans Integrated Service Network (VISN) 17, valued at $6.7 million through December...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D626F24CCDelivery Order
The Defense Logistics Agency Medical Supply Chain awarded Cepheid Inc. a firm fixed-price delivery order valued at $36,720 on January 23, 2026, with completion expected by January 30, 2026. This delivery order, designated XPRS4PLEX-10, represents a child contract under Cepheid's single-award Indefinite Delivery Contract with the Department of Veterans Affairs Veterans Integrated Service Network (VISN) 17, valued at $6.7 million through December 28, 2029. The contract does not utilize a set-aside designation and will be performed at Cepheid's headquarters in Sunnyvale, California. Based on the contract designation, this delivery order likely involves XPRS4PLEX-10 diagnostic cartridges—multiplex molecular diagnostic test cartridges designed for the GeneXpert platform to detect multiple respiratory pathogens. Cepheid has established itself as a primary federal supplier of advanced molecular diagnostic systems and reagents across multiple defense and civilian healthcare agencies, including the VA, Indian Health Service, Defense Health Agency, and U.S. Coast Guard. The company's GeneXpert diagnostic platform serves as the foundation for federal infectious disease testing capabilities, with particular emphasis on rapid molecular diagnostics for COVID-19, influenza, respiratory syncytial virus, and other critical pathogens. This delivery order supports the VA's ongoing requirement for diagnostic reagents and test kits to sustain clinical laboratory operations across its distributed network of medical centers and integrated service networks.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $36.7k | 1/22/26 |